These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24459064)

  • 1. Genomic characterization of three urinary bladder cancer cell lines: understanding genomic types of urinary bladder cancer.
    Pinto-Leite R; Carreira I; Melo J; Ferreira SI; Ribeiro I; Ferreira J; Filipe M; Bernardo C; Arantes-Rodrigues R; Oliveira P; Santos L
    Tumour Biol; 2014 May; 35(5):4599-617. PubMed ID: 24459064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies.
    Earl J; Rico D; Carrillo-de-Santa-Pau E; Rodríguez-Santiago B; Méndez-Pertuz M; Auer H; Gómez G; Grossman HB; Pisano DG; Schulz WA; Pérez-Jurado LA; Carrato A; Theodorescu D; Chanock S; Valencia A; Real FX
    BMC Genomics; 2015 May; 16(1):403. PubMed ID: 25997541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal imbalances in successive moments of human bladder urothelial carcinoma.
    Nascimento e Pontes MG; da Silveira SM; Trindade Filho JC; Rogatto SR; Viana de Camargo JL
    Urol Oncol; 2013 Aug; 31(6):827-35. PubMed ID: 21763161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization.
    Hurst CD; Fiegler H; Carr P; Williams S; Carter NP; Knowles MA
    Oncogene; 2004 Mar; 23(12):2250-63. PubMed ID: 14968109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling.
    Harding MA; Arden KC; Gildea JW; Gildea JJ; Perlman EJ; Viars C; Theodorescu D
    Cancer Res; 2002 Dec; 62(23):6981-9. PubMed ID: 12460916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.
    Hurst CD; Tomlinson DC; Williams SV; Platt FM; Knowles MA
    Oncogene; 2008 Apr; 27(19):2716-27. PubMed ID: 18037967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinoma.
    Rebouissou S; Hérault A; Letouzé E; Neuzillet Y; Laplanche A; Ofualuka K; Maillé P; Leroy K; Riou A; Lepage ML; Vordos D; de la Taille A; Denoux Y; Sibony M; Guyon F; Lebret T; Benhamou S; Allory Y; Radvanyi F
    J Pathol; 2012 Jul; 227(3):315-24. PubMed ID: 22422578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence and location of TP53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancer.
    Markl ID; Jones PA
    Cancer Res; 1998 Dec; 58(23):5348-53. PubMed ID: 9850064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel tumor subgroups of urothelial carcinoma of the bladder defined by integrated genomic analysis.
    Hurst CD; Platt FM; Taylor CF; Knowles MA
    Clin Cancer Res; 2012 Nov; 18(21):5865-5877. PubMed ID: 22932667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of potential target genes of the 6p22.3-amplicon in urinary bladder cancer].
    Oeggerli M; Schraml P; Novotny H; Sauter G; Simon R
    Verh Dtsch Ges Pathol; 2005; 89():219-24. PubMed ID: 18035695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines.
    Koch A; Hatina J; Rieder H; Seifert HH; Huckenbeck W; Jankowiak F; Florl AR; Stoehr R; Schulz WA
    Cell Oncol (Dordr); 2012 Aug; 35(4):243-57. PubMed ID: 22669776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary Exosomal and cell-free DNA Detects Somatic Mutation and Copy Number Alteration in Urothelial Carcinoma of Bladder.
    Lee DH; Yoon H; Park S; Kim JS; Ahn YH; Kwon K; Lee D; Kim KH
    Sci Rep; 2018 Oct; 8(1):14707. PubMed ID: 30279572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors.
    Veltman JA; Fridlyand J; Pejavar S; Olshen AB; Korkola JE; DeVries S; Carroll P; Kuo WL; Pinkel D; Albertson D; Cordon-Cardo C; Jain AN; Waldman FM
    Cancer Res; 2003 Jun; 63(11):2872-80. PubMed ID: 12782593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homozygous losses detected by array comparative genomic hybridization in multiplex urothelial carcinomas of the bladder.
    Beothe T; Zubakov D; Kovacs G
    Cancer Genet; 2015 Sep; 208(9):434-40. PubMed ID: 26235493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA.
    López V; González-Peramato P; Suela J; Serrano A; Algaba F; Cigudosa JC; Vidal A; Bellmunt J; Heredero O; Sánchez-Carbayo M
    J Transl Med; 2013 Aug; 11():182. PubMed ID: 23914742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer.
    Sauter G; Moch H; Carroll P; Kerschmann R; Mihatsch MJ; Waldman FM
    Int J Cancer; 1995 Apr; 64(2):99-103. PubMed ID: 7615360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma.
    Lindgren D; Sjödahl G; Lauss M; Staaf J; Chebil G; Lövgren K; Gudjonsson S; Liedberg F; Patschan O; Månsson W; Fernö M; Höglund M
    PLoS One; 2012; 7(6):e38863. PubMed ID: 22685613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic deletions of cell growth regulators during progression of bladder cancer.
    Primdahl H; von der Maase H; Christensen M; Wolf H; Orntoft TF
    Cancer Res; 2000 Dec; 60(23):6623-9. PubMed ID: 11118045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic characterization of the murine bladder cancer model MB49 and the derived invasive line MB49-I.
    Fabris VT; Lodillinsky C; Pampena MB; Belgorosky D; Lanari C; Eiján AM
    Cancer Genet; 2012 Apr; 205(4):168-76. PubMed ID: 22559978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization.
    Stadler WM; Steinberg G; Yang X; Hagos F; Turner C; Olopade OI
    Clin Cancer Res; 2001 Jun; 7(6):1676-82. PubMed ID: 11410506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.